RXO (RXO) Price Target
Track Wall Street analyst price targets and coverage changes.
Consensus Price Target
$22.00
▲
34.1%
Upside
based on current price $16.41
High Target
$28.00
Median Target
$19.00
Low Target
$19.00
Analyst Coverage
Last Month
1
$19.00
Last Quarter
2
$19.00
Last Year
12
$25.75
Individual Price Targets
Latest Analyst Coverage
| Date | Analyst | Firm | Target | Price When Posted | Upside | News |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | Lucas Servera | Truist Financial | $19.00 | $13.62 | 39.6% | RXO Inc. price target lowered to $19 from $24 at Truist |
| Mar 07, 2025 | Deutsche Bank | $19.00 | $19.81 | 0.0% | RXO Inc. initiated with a Hold at Deutsche Bank | |
| Jan 07, 2025 | Christian Wetherbee | Wells Fargo | $28.00 | $25.30 | 10.7% | RXO Inc. price target lowered to $28 from $31 at Wells Fargo |
| Nov 18, 2024 | Jordan Alliger | Goldman Sachs | $29.00 | $28.72 | 1.0% | Goldman Sachs Reinstates RXO, Inc. (RXO) at Neutral |
| Oct 08, 2024 | Ariel Rosa | Citigroup | $33.00 | $27.62 | 19.5% | RXO Inc. initiated with a Buy at Citi |
| Sep 26, 2024 | Bascome Majors | Susquehanna | $16.00 | $27.88 | 0.0% | RXO Inc. price target lowered to $16 from $20 at Susquehanna |
| Sep 17, 2024 | Scott Schneeberger | Oppenheimer | $31.00 | $25.96 | 19.4% | Oppenheimer Reiterates Outperform Rating on RXO, Inc. (RXO) |
| Sep 11, 2024 | Stephanie Moore | Jefferies | $31.00 | $25.26 | 22.7% | Jefferies Reiterates Buy Rating on RXO, Inc. (RXO) |
| Jul 08, 2024 | Daniel Imbro | Stephens | $25.00 | $26.77 | 0.0% | RXO Inc. price target raised to $25 from $22 at Stephens |
| Jun 25, 2024 | Bruce Chen | Stifel Nicolaus | $26.00 | $24.81 | 4.8% | RXO, Inc. (RXO) PT Raised to $26 at Stifel |
| Jun 24, 2024 | Stephanie Moore | Jefferies | $30.00 | $24.85 | 20.7% | RXO, Inc. (RXO) PT Raised to $30 at Jefferies |
| Jun 20, 2024 | Tom Wadewitz | UBS | $22.00 | $20.06 | 9.7% | UBS Reiterates Neutral Rating on RXO, Inc. (RXO) |
Related Metrics
Explore detailed financial metrics and analysis for RXO.